Logo

Tm Bioscience Concludes Licensing Agreement With Abbott

Oct 04, 2005

NEW YORK, Oct. 4 (GenomeWeb News) - Tm Bioscience has concluded its non-exclusive license agreement with Abbott for certain intellectual property in areas including human and pathogen genotyping, the company said today.

 

The worldwide license expires with the associated patents and "covers Tm's current and future products in all fields of use," the company said.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.